Recombinant Human Erythropoietin Improves Gut Barrier Function in a Hemorrhagic Shock and Resuscitation Rat Model
Capt Raymond L. C. Kao(Lawson Health Research Institute), Claudio M. Martin(Western University), David K. Driman(London Health Sciences Centre), Anargyros Xenocostas(Western University), Rui Tao(Anhui Medical University), Weixiong Huang(Guangdong Provincial Center for Disease Control and Prevention), Xiujun Jiao(Lawson Health Research Institute)
The Journal of Trauma: Injury, Infection, and Critical Care
November 1, 2011
Cited by 18
Related Papers
A Multicenter, Randomized, Controlled Clinical Trial of Transfusion Requirements in Critical Care
|New England Journal of Medicine|1999|5.2k
DALI: Defining Antibiotic Levels in Intensive Care Unit Patients: Are Current -Lactam Antibiotic Doses Sufficient for Critically Ill Patients?
|Clinical Infectious Diseases|2014|1.1k
Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study
|Intensive Care Medicine|2001|984
Is a low transfusion threshold safe in critically ill patients with cardiovascular diseases?
|Critical Care Medicine|2001|597